[Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
D000449:Aldehyde Reductase / Q000032:analysis / Q000037:antagonists & inhibitors*; D000818:Animals; D002386:Cataract / Q000473:pathology / Q000517:prevention & control*; D005693:Galactosemias / Q000150:complications*; D006651:Histocytochemistry; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D048289:Imidazolidines; D007908:Lens, Crystalline / Q000201:enzymology / Q000648:ultrastructure*; D009883:Ophthalmic Solutions; D051381:Rats; D011919:Rats, Inbred Strains; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*
D007093:Imidazoles; D048289:Imidazolidines; D009883:Ophthalmic Solutions; C037070:M 79175; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase